Creating open-tech standards for better trial collaboration and execution

Advanced Clinical joins Align Clinical CRO, a group dedicated to making it easier for sponsors and CROs to work together on trials
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
DEERFIELD, Ill.—Advanced Clinical, a clinical development organization providing contract research, functional service provider, strategic resourcing and quality and validation services, announced in late June that it has joined Align Clinical CRO, a new industry standards group dedicated to making it easier for sponsors and contract research organizations to work together during clinical trials.
“Align Clinical CRO’s mission is directly in line with our goal of delivering a better clinical experience to sponsors. As a member of this powerful industry collaboration, we will help develop and drive new technology standards that will improve operational delivery of clinical trials,” said Julie Ross, president of Advanced Clinical.
Continue reading below...
Illustration of diverse healthcare professionals interacting with digital medical data and health records on virtual screens.
WebinarsAccelerating rare disease clinical trials
Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.
Read More
Align Clinical CRO aims to develop and support the adoption of open technology standards that make it easier for industry sponsors and CROs to collaborate and execute clinical trials. Founded by Veeva Systems and leading CROs, the group’s first standard for operational data exchange will define the data and structure that technology companies can implement in order to consistently and easily exchange clinical trial data between CROs and sponsors. With more efficient CRO-sponsor data exchange, these standards will reduce clinical trial start up time and operational costs while improving data integrity and service delivery.
The Operational Data Exchange Standard is expected to be published for public review and input later this year.

Related Topics

Published In

Volume 14 - Issue 7 | July 2018

July 2018

July 2018 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue